Christelle Haziza
      OUR PEOPLE

      Dr. Christelle Haziza

      PhD in Molecular Biology, Postgraduate Diploma in Human Pharmacology

      Head Scientific and Medical Affairs - Rest of the World

      Contact

      Christelle is Head Scientific and Medical Affairs. She holds a PhD in Molecular Biology from the University of Rennes 1, France, and a Postgraduate Diploma in Human Pharmacology from King’s College, London, U.K.  

      Christelle has in-depth experience in clinical study design and execution under Good Clinical Practice, as well as expertise in cardiovascular and pulmonary diseases. She joined PMI in 2007 and has held various roles, including Director Health Science and Biostatistics, Manager Clinical Research and Development, and Global Head of Clinical Research and Operations. Prior to joining PMI, she worked in an academic environment. Christelle has published numerous articles in international peer-reviewed scientific journals. 

      Latest Publications

      PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts in support of its smoke-free product portfolio. This site is a global site for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not advertising or marketing, nor is it directed at any specific market. It is not intended for use by consumers. New tobacco products sold in the United States are subject to FDA regulation; therefore the content of this site is not intended to make, and nor should it be construed as making, any product related claims in the United States without proper FDA authorization. ​
      ​
      Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. All of our RRPs are smoke-free products that deliver nicotine with far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.